A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

The global sales of Zika virus testing is estimated to be worth USD 244.7 million in 2025 and anticipated to reach a value of ...

Oxford BioDynamics has welcomed a new report that calls for the introduction of targeted prostate cancer screening in the UK.

It's officially flu season. You've been invited to a get-together with friends and would love to attend, but have been ...

Innovative graphene-silver metasurface biosensor combines nanotech and AI, providing real-time, label-free COVID-19 detection for future diagnostic applications.

Siemens Healthineers on Wednesday announced the launch of a rapid antigen test kit in Europe to detect coronavirus infections, but warned that the industry may struggle to meet a surge in demand.

Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued efforts to diagnose and trace those ...

Opportunities in the COVID-19 diagnostics market include growing demand for rapid and precise diagnostic tests, especially mass and molecular diagnostics, innovation in at-home testing kits, and ...

Importance of Differential Diagnosis  With Respiratory Season rapidly approaching the Northern Hemisphere, clinic | Clinical ...

Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19.

As flu season arrives, a new highly infectious COVID-19 variant, Stratus (XFG), is driving a surge in US cases, first ...

Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...